Asthma and reproductive outcomes: A Danish nationwide cohort study

Vejen Hansen,A.,Hakansson,K. E. J.,Mikkelsen,A. P.,Ali,Z.,Pinborg,A.,Lidegaard,O.,Ulrik,C. S.
DOI: https://doi.org/10.1183/13993003.congress-2024.oa5579
IF: 24.3
2024-11-01
European Respiratory Journal
Abstract:Background: Asthma is common among women of reproductive age. Prior studies revealed associations between asthma and fertility by reporting prolonged time to pregnancy and altered fecundability. Aim: Investigate fertility in women treated with anti-asthmatic drugs (ICS/LABA/LAMA/SABA/LTRA) compared to non-asthmatic controls. Method: All Danish women born 1976 to 1999 were followed from 1994 to 2017. Asthma was identified by repeated redemption of anti-asthmatic drugs with severity per 2018 GINA guidelines. Outcome were fertility treatment, compared to controls applying a Cox regression model adjusted for age, calendar year, and education. Results: In total, 769,880 were included and followed (median time of 10.8 years [IQR 5.3-17.5]). The proportion who gave birth in follow-up was 77%, irrespective of asthma exposure. However, women with asthma experienced higher degree of fetal loss (17.0% vs. 15.7%) and more use of fertility treatment (5.6% vs. 5.0%) compared to controls. Risk of fertility treatment was significantly higher in women with asthma: HR 1.12(1.08-1.15). GINA step 4-5 had the highest risk of needing fertility treatment: HR 1.62(1.43-1.83) and women with ≥ 3 prior exacerbations had an increased risk of needing fertility treatment: HR 1.38(1.19-1.60). Conclusion: Although women with asthma more often require fertility treatment, a risk correlated to asthma severity and exacerbations, asthma does not seem to affect the number of live births.
respiratory system
What problem does this paper attempt to address?